BRAF and melanoma: In melanomas, tumor transformation is often driven by the dysregulation of the mitogen-activated-protein-kinase (MAPK)-proliferation signaling pathway as a consequence of BRAF and NRAS mutations seen in 50% and 20% of cases, respectively [7,8].